EU for Evibodies
By Kate McDonald
Monday, 09 February, 2009
Monday, 09 February, 2009
Arana Therapeutics has been granted an EU patent for its Evibodies range of small antibodies.
Evibodies were part of the technology platform brought into the company by EvoGenix when it merged with Peptech in 2007.
Evibodies are small fragments of a family of proteins that act like antibodies but are about one-tenth smaller.
They were given a US patent in 2007.
Related News
Noxopharm says paper reveals science behind its immune system platform
Clinical-stage Australian biotech company Noxopharm Limited says a Nature Immunology...
Neurosensing/neurostimulation implants session to be held on Monday
On Monday, a session at UNSW Sydney will include people who are benefiting from bioelectronics...
argenx and Monash University partner against autoimmune diseases
To advance a pioneering molecule for autoimmune diseases, global immunology company argenx has...
